Antonio Molinaro

  • Post doc; PhD
 

Publications 2025

Molinaro A, Engesæter LK, Jorns C, Nordin A, Rasmussen A, Line PD, Pall V, Ericzon BG, Bennet W, Hov JR, Melum E (2025)
Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis
Liver Int, 45 (1), e16214
DOI 10.1111/liv.16214, PubMed 39679639

Publications 2024

Jaeger JW, Brandt A, Gui W, Yergaliyev T, Hernández-Arriaga A, Muthu MM, Edlund K, Elashy A, Molinaro A, Möckel D, Sarges J, Halibasic E, Trauner M, Kahles F, Rolle-Kampczyk U, Hengstler J, Schneider CV, Lammers T, Marschall HU, von Bergen M, Camarinha-Silva A, Bergheim I, Trautwein C, Schneider KM (2024)
Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression
JHEP Rep, 6 (3), 100987
DOI 10.1016/j.jhepr.2023.100987, PubMed 38328439

Molinaro A, Wauters L (2024)
Young GI angle: UEG research fellowship-Benefits of going abroad
United European Gastroenterol J, 12 (7), 984-985
DOI 10.1002/ueg2.12654, PubMed 39207814

Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024)
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
Genome Med, 16 (1), 27
DOI 10.1186/s13073-024-01296-6, PubMed 38331891

Trøseid M, Molinaro A, Gelpi M, Vestad B, Kofoed KF, Fuchs A, Køber L, Holm K, Benfield T, Ueland PM, Hov JR, Nielsen SD, Knudsen AD (2024)
Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV
J Infect Dis, 229 (3), 898-907
DOI 10.1093/infdis/jiad604, PubMed 38195204

Publications 2023

Gui W, Hole MJ, Molinaro A, Edlund K, Jørgensen KK, Su H, Begher-Tibbe B, Gaßler N, Schneider CV, Muthukumarasamy U, Mohs A, Liao L, Jaeger J, Mertens CJ, Bergheim I, Strowig T, Hengstler JG, Hov JR, Marschall HU, Trautwein C, Schneider KM (2023)
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
Nat Commun, 14 (1), 3304
DOI 10.1038/s41467-023-38840-8, PubMed 37280200